Event Lowering News Today

While a Korean study shows reduction in diabetic retinopathy progression by 11% with fenofibrate plus statin compared with statin alone, some reservations remain over wider use.

People with diabetic retinopathy who took the cholesterol-lowering drug fenofibrate were less likely to progress to vision-threatening forms of the disease, in a large database study.